UMass Medical School
Mission Statement
At a Glance
0
Educational Resources Posted
1
Consortium News Stories Posted
1
Events Posted
2
Opportunities Posted
Coming Soon
Publications citing CTSA Program Grant
6
Users from Hub Registered
UL1 Award
KL2 Award
TL1 Award
UL1
UL1 Administrator
Enterprise Committees
Collaboration and Engagement Voting Member
- StephenieLemonChief, Division of Preventive and Behavioral Medicine
Events

Funding Opportunity-Point of Care Technologies
Do you have a promising point-of-care medical technology in need of further development? The NIH’s Point-of-Care Technology Research Network (POCTRN) drives the development of point-of-care technologies through collaborative efforts that merge scientific and technological capabilities with clinicalOpportunities
IRB Analyst
Under the direction of the Director or designee, the Internal Review Board (IRB) Analyst reviews IRB submissions ensuring efficient and effective research compliance with institutional, state and federal policies and regulations. The IRB Analyst takes a proactive role in defining, evaluating, and
Contract Administrator
We're seeking a highly motivated and dynamic Contract Administrator II to join the Medical School. The position will be primarily responsible for facilitating all aspects of the contracting and financial management for clinical research projects including reviewing of protocol documents and schedule
Posters
Improving Access to Research Among Individuals from Under-represented Racial and Ethnic Minority Communities: The Strengthening Research In Diverse Enrollment (STRIDE) Study
INTRODUCTION Under-representation in health-related research is one of a multitude of factors that contribute to health disparities experienced by African American and Latinx communities, and has been brought to the forefront in the context of the COVID-19 pandemic. Barriers to research

Novel Integrative Markers to Define Human Disease
The goal of this proposal is to establish the UMass Integrative Biomarker Center (InBioC) that will apply powerful new technologies (genomic, proteomic, metabolomic, imaging technologies, nanotechnologies) and integrative analytics to well-curated human samples in order to clarify biological